Financing

Intrexon injected with funds

Published in Lab Law Weekly, June 1st, 2007

Intrexon Corp., a 45-employee life sciences company at the Virginia Tech Corporate Research Center in Blacksburg, has received $25 million in Series C financing from New River Management, a private investment fund managed by Radford-based Third Security.

Intrexon president and chief executive Robert Beech said the investment should allow the privately held company to grow to roughly three times its current size, or about 130 employees by the end of this year.

The bulk of those employees will likely do research and development associated with Intrexon's pre-clinical studies in gene-based therapy.

The company develops new ways to...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2007-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry